Ekso Bionics Holdings, Inc. (EKSO) NASDAQ
11.80
+0.15(+1.29%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
11.80
+0.15(+1.29%)
Currency In USD
| Previous Close | 11.65 |
| Open | 11.4 |
| Day High | 11.8 |
| Day Low | 11.4 |
| 52-Week High | 13.5 |
| 52-Week Low | 2.73 |
| Volume | 95,135 |
| Average Volume | 78,942 |
| Market Cap | 28.63M |
| PE | -2.31 |
| EPS | -5.11 |
| Moving Average 50 Days | 10.62 |
| Moving Average 200 Days | 6.93 |
| Change | 0.15 |
Data not available
Ekso Bionics Prices $5.852 million Private Placement
GlobeNewswire Inc.
Jan 21, 2026 1:30 PM GMT
SAN RAFAEL, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that on January 20, 2026 it entered into securitie
Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch’s Groundbreaking BalanceTutor™ Rehabilitation System
GlobeNewswire Inc.
Dec 04, 2025 12:45 PM GMT
SAN RAFAEL, Calif. and TNUVOT, Israel, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics” or the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that
Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
GlobeNewswire Inc.
Oct 29, 2025 12:00 PM GMT
SAN RAFAEL, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that on October 28, 2025, it entered into a defini